Reducing Pharmaceutical Prices Requires Competition, Not Price-Fixing | National Review

Reducing Pharmaceutical Prices Requires Competition, Not Price-Fixing | National Review

May 20, 2025 / Swedan Margen /




Cutting the red tape around biosimilars is one way that the administration can protect U.S. drug innovation and make medicine more affordable for Americans.



Source link

Posted in

Swedan Margen

I focus on highlighting the latest in business and entrepreneurship. I enjoy bringing fresh perspectives to the table and sharing stories that inspire growth and innovation.

Leave a Comment